Literature DB >> 365781

Reactive antibodies in the bronchial washings of lung cancer patients.

E Paluch, H L Ioachim.   

Abstract

Lung-carcinoma-reactive antibodies have been previously isolated from tumor tissues and pleural effusions. To explore the immunoglobulin (Ig) content of bronchial secretions, bronchial washings of patients with inflammatory and neoplastic lung diseases were studied with respect to Ig levels and specificity. Expressed as Ig/potassium ratios, statistically significant increases in Ig levels were found in inflammatory diseases and even higher increases in lung carcinomas. The isolation of Ig from bronchial washings was achieved by dissociation of immune complexes at low pH, neutralization and subsequent purification by anion exchange chromatography. The isolated immunoglobulins were tested in indirect immunofluorescence against lung cancer cells of various histologic types in tissue cultures and fresh suspensions. Positive cytoplasmic fluorescence was obtained with cells of adeno carcinomas and squamous-cell carcinomas of the lung but not with cells of normal lung. The accessibility of bronchial washings makes the investigation of their lung-cancer-reactive immunoglobulins relatively easy and raises the possibility of its eventual conversion into a screening test.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 365781     DOI: 10.1002/ijc.2910230109

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Detection of disease specific sialoglycoconjugate specific antibodies in bronchoalveolar lavage fluid of non-small cell lung cancer patients.

Authors:  Sangeeta Mehta; Rakhee Chhetra; Radhika Srinivasan; Suresh C Sharma; Digambar Behera; Sujata Ghosh
Journal:  Glycoconj J       Date:  2010-05-16       Impact factor: 2.916

2.  Activity of antibodies recovered from immune complexes of ovarian cancer patients.

Authors:  P M Lutz; J R Dawson
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Local responses in primary and secondary human lung cancers. II. Clinical correlations.

Authors:  E Kolb; E Müller
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.